Illumina/ US4523271090 /
4/22/2025 9:59:59 PM | Chg. +2.31 | Volume | Bid9:59:59 PM | Ask9:59:59 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
74.35USD | +3.21% | 117,183 Turnover: 8.67 mill. |
74.27Bid Size: 100 | 74.35Ask Size: 100 | 11.78 bill.USD | - | - |
GlobeNewswire
4/16
Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Stra...
GlobeNewswire
4/15
Attovia Therapeutics Announces $90 Million Series C Financing to Advance ATTOBODY-based Programs thr...
GlobeNewswire
3/27
Galatea Bio Secures $25M to Develop Global Biobank and Enable Precision Health at Scale for All
GlobeNewswire
3/14
Gradalis Announces Development of Clinically Relevant Exome Sequencing Bioinformatics Pipeline to De...
GlobeNewswire
2/18
LexisNexis Announces “Top 100 Global Innovators” for 2025, Recognizing Leading Companies Driving Inn...
GlobeNewswire
8/1/2024
Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...
GlobeNewswire
7/29/2024
Palisade Bio Successfully Completes Microbiome Study Confirming Bacterial Enzymes for Local Bioactiv...
GlobeNewswire
7/23/2024
Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing
GlobeNewswire
7/9/2024
Paragon Genomics Partners with Biosecure ID to Expand Access to CleanPlex® Technology in the UK and ...
GlobeNewswire
6/20/2024
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research
GlobeNewswire
6/3/2024
AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen a...